A new central direct dopaminergic stimulant: 1-(Coumaran-5-yl methyl)-4-(2-thiazolyl) piperazine hydrochloride (S 3608)
- 1 October 1975
- journal article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 31 (10) , 1204-1205
- https://doi.org/10.1007/bf02326795
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the ratEuropean Journal of Pharmacology, 1974
- Dopamine agonist and antagonist activities of piribedil (ET495) and its metabolitesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974
- Preliminary investigation of the metabolism of piribedil (ET 495); a new central dopaminergic agonist and potential anti-parkinson agentJournal of Pharmacy and Pharmacology, 1973
- Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neuronsJournal of Pharmacy and Pharmacology, 1973
- The site and mode of action of ET495 for the mediation of stereotyped behaviour in the ratNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1973
- ET495 and brain catecholamine mechanisms: Evidence for stimulation of dopamine receptorsEuropean Journal of Pharmacology, 1972
- Evidence for a new type of dopamine receptor stimulating agentJournal of Pharmacy and Pharmacology, 1971
- Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine systemBrain Research, 1970
- Synthesis and vasodilator activity of new piperazine derivativesJournal of Medicinal Chemistry, 1968
- Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsPsychopharmacology, 1967